Trinity Biotech plc (TRIB)

NASDAQ: TRIB · Real-Time Price · USD

9.68

-0.07 (-0.72%)

At close: Aug 28, 2026, 4:00 PM EDT

9.60

-0.08 (-0.83%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Trinity Biotech Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	43.79	43.79	61.56	56.83	62.52	81.15
Revenue Growth	-28.87%	-28.87%	8.31%	-9.10%	-22.96%	-20.43%
Gross Profit	16.89	16.89	21.44	19.45	17.27	33.45
Operating Income	-9.55	-9.55	-13.7	-15.94	-13.51	6.46
Net Income	-37.38	-37.38	-31.79	-24.02	-41.01	0.88
Earnings Per Share	-60.36	-60.36	-60.96	-94.13	-182.34	6.28
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Clinical Laboratory Goods	31.68	31.68	39.37	42.29	46.04
Clinical Laboratory Services	4.01	4.01	4.75	5.45	7.27
Point-Of-Care Products	8.1	8.1	17.43	9.09	9.21
Total	43.79	43.79	61.56	56.83	62.52

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	5.14	5.14	5.17	3.69	6.58	25.91
Total Debt	137.98	137.98	100.76	67.43	72.2	99.16
Net Cash (Debt)	-132.85	-132.85	-95.6	-63.74	-65.62	-73.25
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-214.55	-214.55	-159.69	-249.78	-291.78	-525.65

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-5.93	-5.93	-4.19	-11.56	-0.92	13.24
Capital Expenditures	-0.09	-0.09	-0.41	-0.8	-1.1	-1.81
Free Cash Flow	-6.02	-6.02	-4.6	-12.36	-2.02	11.43
Free Cash Flow Growth	-	-	-	-	-	-44.39%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.57%	38.57%	34.83%	34.22%	27.62%	41.23%
Operating Margin	-21.80%	-21.80%	-22.26%	-28.05%	-21.61%	7.96%
Pretax Margin	-84.91%	-84.91%	-49.92%	-64.98%	-70.02%	-2.37%
Profit Margin	-85.36%	-85.36%	-51.64%	-42.26%	-65.59%	1.08%
FCF Margin	-13.74%	-13.74%	-7.47%	-21.75%	-3.23%	14.08%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	34.16
Forward PE	-	24.20	24.20	24.20	24.20	28.60
P/FCF Ratio	-	-	-	-	-	2.62
PS Ratio	0.18	0.34	0.25	0.29	0.60	0.37